C.M. Bidwell & Associates’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.94K | Hold |
11
| – | – | ﹤0.01% | 376 |
|
|
2025
Q4 | $2.76K | Hold |
11
| – | – | ﹤0.01% | 372 |
|
|
2025
Q3 | $3.16K | Hold |
11
| – | – | ﹤0.01% | 376 |
|
|
2025
Q2 | $2.89K | Hold |
11
| – | – | ﹤0.01% | 368 |
|
|
2025
Q1 | $2.56K | Hold |
11
| – | – | ﹤0.01% | 375 |
|
|
2024
Q4 | $2.52K | Hold |
11
| – | – | ﹤0.01% | 416 |
|
|
2024
Q3 | $2.46K | Hold |
11
| – | – | ﹤0.01% | 430 |
|
|
2024
Q2 | $2.24K | Hold |
11
| – | – | ﹤0.01% | 407 |
|
|
2024
Q1 | $2.4K | Hold |
11
| – | – | ﹤0.01% | 407 |
|
|
2023
Q4 | $2.5K | Hold |
11
| – | – | ﹤0.01% | 416 |
|
|
2023
Q3 | $2.21K | Sell |
11
-2
| -15% | -$422 | ﹤0.01% | 447 |
|
|
2023
Q2 | $2.65K | Hold |
13
| – | – | ﹤0.01% | 440 |
|
|
2023
Q1 | $2.52K | Hold |
13
| – | – | ﹤0.01% | 436 |
|
|
2022
Q4 | $2.59K | Sell |
13
-1,806
| -99% | -$353K | ﹤0.01% | 415 |
|
|
2022
Q3 | $320K | Buy |
1,819
+1,224
| +206% | +$251K | 0.27% | 66 |
|
|
2022
Q2 | $120K | Sell |
595
-1,185
| -67% | -$253K | 0.09% | 194 |
|
|
2022
Q1 | $403K | Sell |
1,780
-4
| -0.2% | -$941 | 0.26% | 59 |
|
|
2021
Q4 | $482K | Buy |
1,784
+1,187
| +199% | +$294K | 0.3% | 51 |
|
|
2021
Q3 | $144K | Hold |
597
| – | – | 0.1% | 203 |
|
|
2021
Q2 | $142K | Buy |
597
+5
| +0.8% | +$1.14K | 0.09% | 206 |
|
|
2021
Q1 | $130K | Buy |
592
+274
| +86% | +$55K | 0.1% | 193 |
|
|
2020
Q4 | $56K | Buy |
318
+305
| +2,346% | +$52.7K | 0.05% | 278 |
|
|
2020
Q3 | $2K | Hold |
13
| – | – | ﹤0.01% | 422 |
|
|
2020
Q2 | $2K | Hold |
13
| – | – | ﹤0.01% | 377 |
|
|
2020
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 333 |
|
|
2019
Q4 | $2K | Hold |
13
| – | – | ﹤0.01% | 381 |
|
|
2019
Q3 | $2K | Sell |
13
-209
| -94% | -$30.5K | ﹤0.01% | 390 |
|
|
2019
Q2 | $33K | Buy |
222
+209
| +1,608% | +$29.2K | 0.03% | 279 |
|
|
2019
Q1 | $2K | Hold |
13
| – | – | ﹤0.01% | 366 |
|
|
2018
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 373 |
|
|
2018
Q3 | $2K | Hold |
13
| – | – | ﹤0.01% | 354 |
|
|
2018
Q2 | $2K | Hold |
13
| – | – | ﹤0.01% | 380 |
|
|
2018
Q1 | $2K | Hold |
13
| – | – | ﹤0.01% | 353 |
|
|
2017
Q4 | $2K | Hold |
13
| – | – | ﹤0.01% | 361 |
|
|
2017
Q3 | $2K | Hold |
13
| – | – | ﹤0.01% | 274 |
|
|
2017
Q2 | $2K | Buy |
+13
| New | +$1.59K | ﹤0.01% | 288 |
|
|
2016
Q4 | – | Sell |
-33,692
| Closed | -$3.98M | – | 273 |
|
|
2016
Q3 | $3.98M | Buy |
33,692
+157
| +0.5% | +$18.5K | 0.95% | 44 |
|
|
2016
Q2 | $3.75M | Buy |
+33,535
| New | +$3.61M | 0.93% | 51 |
|
Other funds holding LH
VCM
VPM
C.M. Bidwell & Associates's LH Position: Q1 2026 in Review
C.M. Bidwell & Associates held its Labcorp (LH) position steady in Q1 2026 at 11 shares worth $2.94K. The position accounts for ﹤0.01% of the portfolio, ranked #376.
C.M. Bidwell & Associates first reported a position in LH in Q2 2016 and has held it in 38 quarters since. The position peaked at $3.98M in Q3 2016. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- C.M. Bidwell & Associates held 11 shares of Labcorp worth $2.94K as of Q1 2026.
- C.M. Bidwell & Associates left its Labcorp share count unchanged in Q1 2026.
- Labcorp made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q1 2026, its #376 holding.
- C.M. Bidwell & Associates first reported a position in Labcorp in Q2 2016 and has held it in 38 quarters since.
- C.M. Bidwell & Associates's Labcorp position peaked at $3.98M in Q3 2016.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.